XML 29 R22.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Nov. 01, 2025
Schedule of Stock-based Compensation Expense | For the thirteen and thirty-nine weeks ended November 1, 2025 and November 2, 2024, stock-based compensation expense was comprised of the following:
(In thousands) |  | Thirteen Weeks Ended November 1, 2025 |  |  | Thirteen Weeks Ended November 2, 2024 |  |  | Thirty-nine Weeks Ended November 1, 2025 |  |  | Thirty-nine Weeks Ended November 2, 2024 |
Share-settled equity awards |  | $ | 2,011 |  |  | $ | 1,623 |  |  | $ | 5,640 |  |  | $ | 4,926 |
Stock appreciation rights |  |  | 0 |  |  |  | 0 |  |  |  | 0 |  |  |  | 221 |
Employee Stock Purchase Plan |  |  | 7 |  |  |  | 7 |  |  |  | 24 |  |  |  | 57 |
Total stock-based compensation expense |  | $ | 2,018 |  |  | $ | 1,630 |  |  | $ | 5,664 |  |  | $ | 5,204 |
Income tax effect at statutory rates |  | $ | (491 | ) |  | $ | (397 | ) |  | $ | (1,377 | ) |  | $ | (1,266 | )
Additional income tax (benefit) expense on vesting of share-settled awards |  | $ | (3 | ) |  | $ | 0 |  |  | $ | 466 |  |  | $ | (109 | )
Summary of Restricted Stock Awards Transactions | The following table summarizes transactions for our restricted stock and other stock awards:
|  | Number of Shares |  |  | Weighted- Average Grant Date Fair Value |
Outstanding at February 1, 2025 |  |  | 0 |  |  | $ | 0.00 |
Granted |  |  | 34,488 |  |  |  | 18.85 |
Vested |  |  | (5,306 | ) |  |  | 18.85 |
Forfeited |  |  | 0 |  |  |  | 0.00 |
Outstanding at November 1, 2025 |  |  | 29,182 |  |  | $ | 18.85 |
Share-settled Equity Awards |
Summary of Restricted Stock Awards Transactions | The following table summarizes transactions for our restricted stock units and performance stock units:
|  | Number of Shares |  |  | Weighted- Average Grant Date Fair Value |
Outstanding at February 1, 2025 |  |  | 695,259 |  |  | $ | 29.71 |
Granted |  |  | 436,031 |  |  |  | 21.61 |
Vested |  |  | (259,725 | ) |  |  | 28.79 |
Forfeited |  |  | (59,113 | ) |  |  | 29.47 |
Outstanding at November 1, 2025 |  |  | 812,452 |  |  | $ | 25.68 |

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=scvl_RestrictedStockUnitsAndPerformanceStockUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |